Nektar Therapeutics | NKTR - Lucro Bruto Sobre Vendas





Lucro Bruto Sobre Vendas Alterar Data
Agios Pharmaceuticals USD 19.43M 1.34M 2026-03
ALKERMES USD 375.31M 43.98M 2026-06
Amgen USD 5.87B 1.02B 2026-03
Baxter International USD 1.14B 251M 2026-06
BioCryst Pharmaceuticals USD 214.41M 61.36M 2026-06
Biogen USD 2.12B 307M 2026-06
Bristol-Myers Squibb USD 9.26B 1.19B 2026-06
Cara Therapeutics USD 2.57M 1.11M 2025-03
Cipla INR 44.1B 5B 2026-06
Dr.Reddys Laboratories INR 41.78B 4.02B 2026-06
Eisai JPY 183.24B 29.83B 2026-06
Eli Lilly USD 16.22B 301.7M 2026-03
Exelixis USD 608.03M 17.17M 2026-06
Gilead Sciences USD 6.8B 1.29B 2026-06
GlaxoSmithKline GBP 6.51B 757M 2026-06
Grifols EUR 766.49M 39.74M 2024-12
Halozyme Therapeutics USD 297.47M 75.53M 2026-03
Incyte USD 1.57B 400.89M 2026-06
Ionis Pharmaceuticals USD 265M 22M 2026-06
Ironwood Pharmaceuticals USD 85.24M 44.1M 2025-06
Karyopharm Therapeutics USD 33.72M 1.13M 2026-03
MacroGenics USD 11.24M 19.87M 2026-03
Merck USD 12.09B 1.24B 2026-03
Nektar Therapeutics USD 10.86M 10.95M 2026-03
Neurocrine Biosciences USD 800.7M 12.8M 2026-03
Novartis USD 11.24B 1.18B 2026-06
Pfizer USD -248M 11.29B 2026-06
Roche Holding CHF 22.69B 600M 2026-06
Sarepta Therapeutics USD 251.15M 370.2M 2026-06
Takeda JPY 813.22B 124.39B 2026-06
Teva Pharmaceutical Industries USD 2.15B 45M 2026-06
Xencor USD 51.22M 46.7M 2026-06